Clinicians should individualize dosing practices based on patient risk factors and preferences
Results inform dose selection for further trials of the aldosterone synthase inhibitor
Keys to success include a team-based approach and integration into clinical workflow
Home transmission to the medical record, plus ambulatory monitoring for high-risk patients
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Retrospective clinic-based study provides intriguing initial comparisons
A clinical hypertension specialist puts recommendations in context
Three Cleveland Clinic cardiologists size up the ACC/AHA recommendations
Large study examines BP and specific causes of death
Celecoxib has least impact, followed by naproxen and ibuprofen